Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@zohmbastic Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2273512572.png) @zohmbastic zohm

No specific company named "zohm" appears in the provided tweets. However, various companies are trending with updates on earnings, analyst upgrades and downgrades, and new partnerships. Some companies like $MARa, $FIVE, and $RLX reported strong quarterly earnings.

### Engagements: XXXXXX [#](/creator/twitter::2273512572/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:interactions.svg)

- X Week XXXXXXX -XX%
- X Month XXXXXXXXX -XX%
- X Months XXXXXXXXXX +179%
- X Year XXXXXXXXXX +223%

### Mentions: XX [#](/creator/twitter::2273512572/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:posts_active.svg)

- X Week XXX -XX%
- X Month XXXXX -XX%
- X Months XXXXX +110%
- X Year XXXXX +180%

### Followers: XXXXX [#](/creator/twitter::2273512572/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:followers.svg)

- X Week XXXXX +0.72%
- X Month XXXXX +2.20%
- X Months XXXXX +27%
- X Year XXXXX +54%

### CreatorRank: XXXXXXX [#](/creator/twitter::2273512572/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2273512572/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XXXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [finance](/list/finance)  XXXX% [countries](/list/countries)  XXXX% [technology brands](/list/technology-brands)  XXXX% [fashion brands](/list/fashion-brands)  XXXX% [exchanges](/list/exchanges)  XXXX%

**Social topic influence**
[target](/topic/target) #827, [strong](/topic/strong) 2.36%, [price target](/topic/price-target) #20, [$dbrg](/topic/$dbrg) #21, [$sg](/topic/$sg) #3, [morgan stanley](/topic/morgan-stanley) #29, [$tvtx](/topic/$tvtx) #9, [$rvmd](/topic/$rvmd) #23, [$acva](/topic/$acva) 1.68%, [$gh](/topic/$gh) #15

**Top accounts mentioned or mentioned by**
[@maximusholla](/creator/undefined) [@sandman7591](/creator/undefined) [@pnani456](/creator/undefined) [@jefftheomega1](/creator/undefined) [@hannibalspeaks](/creator/undefined) [@doepkemichel](/creator/undefined) [@stocktalkweekly](/creator/undefined) [@margaret252384](/creator/undefined) [@joserestonva](/creator/undefined) [@almightyzeeza](/creator/undefined) [@josericaurtej](/creator/undefined) [@marketprophit](/creator/undefined) [@traderjon01](/creator/undefined) [@boxlongs](/creator/undefined) [@tagthatstock](/creator/undefined) [@byebyegoodguy](/creator/undefined) [@fabiomclean](/creator/undefined) [@fd_coop_ny](/creator/undefined)

**Top assets mentioned**
[DigitalBridge Group, Inc. (DBRG)](/topic/$dbrg) [Sweetgreen, Inc. (SG)](/topic/$sg) [Morgan Stanley (MS)](/topic/morgan-stanley) [Travere Therapeutics, Inc. Common Stock (TVTX)](/topic/$tvtx) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [ACV Auctions Inc. Class A Common Stock (ACVA)](/topic/$acva) [Guardant Health, Inc. Common Stock (GH)](/topic/$gh) [UiPath, Inc. (PATH)](/topic/$path) [Victoria's Secret & Co. (VSCO)](/topic/$vsco) [NVIDIA Corp. (NVDA)](/topic/$nvda) [ADMA Biologics, Inc. (ADMA)](/topic/$adma) [Rocket Companies, Inc. (RKT)](/topic/$rkt) [American Eagle Outfitters (AEO)](/topic/$aeo) [Helium IOT (IOT)](/topic/$iot) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [Exact Sciences Corp (EXAS)](/topic/$exas) [Gapcoin (GAP-1)](/topic/$gap) [A3S Protocol (AA)](/topic/$aa) [Applied Blockchain, Inc. Common Stock (APLD)](/topic/$apld) [Waystar Holding Corp. Common Stock (WAY)](/topic/$way) [PERI Finance (PERI)](/topic/$peri) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Alkermes Inc. plc (ALKS)](/topic/$alks) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Marblex (MBX)](/topic/$mbx) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [One Cash (ONC)](/topic/$onc) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [GRAIL, Inc. Common Stock (GRAL)](/topic/$gral) [Abercrombie & Fitch Co. (ANF)](/topic/$anf) [Smooth Love Potion (SLP)](/topic/$slp) [Warby Parker Inc. (WRBY)](/topic/$wrby) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [Advanced Micro Devices (AMD)](/topic/$amd) [Intel Corporation (INTC)](/topic/$intc) [Neumora Therapeutics, Inc. Common Stock (NMRA)](/topic/$nmra) [Chime Financial, Inc. Class A Common Stock (CHYM)](/topic/$chym) [GlobalFoundries, Inc. (GFS)](/topic/$gfs)
### Top Social Posts
Top posts by engagements in the last XX hours

"$RLMD hit 5"  
[X Link](https://x.com/zohmbastic/status/1991154483024277659)  2025-11-19T14:39Z 9414 followers, 2057 engagements


"$NVDA TRUMP: UNITED STATES WILL ALLOW NVIDIA TO SHIP ITS H200 PRODUCTS TO APPROVED CUSTOMERS IN CHINA AND OTHER COUNTRIES"  
[X Link](https://x.com/zohmbastic/status/1998143322066452595)  2025-12-08T21:31Z 9411 followers, 2593 engagements


"$TERN upgrades HCW XX from XX Mizuho XX from XX Truist XX from XX BMO Capital XX from XX Barclays XX from 36"  
[X Link](https://x.com/zohmbastic/status/1998374434978295962)  2025-12-09T12:49Z 9414 followers, 2638 engagements


"$BMEA BMEA Biomea Fusion Reports Durable Glycemic And C-Peptide Improvements X Months After Last Dose In COVALENT-111 With Icovamenib"  
[X Link](https://x.com/zohmbastic/status/1996934978723012619)  2025-12-05T13:29Z 9415 followers, 2945 engagements


"$NVDA $AMD $INTC TRUMP: SAME APPROACH WILL APPLY TO AMD INTEL AND OTHER GREAT AMERICAN COMPANIES"  
[X Link](https://x.com/zohmbastic/status/1998143832978796982)  2025-12-08T21:33Z 9411 followers, 1587 engagements


"$APLD 28c deep ITM + 500%"  
[X Link](https://x.com/zohmbastic/status/1998424749979185314)  2025-12-09T16:09Z 9414 followers, 1366 engagements


"$CAPR Oppenheimer raised the firm's price target on Capricor Therapeutics to $XX from $XX and keeps an Outperform rating on the shares. Today's announcement that binding terms for deramiocel's European commercialization have been agreed upon with partner Nippon Shinyaku gives Capricor access to another leading pharmaceutical market and signals third-party confidence in global regulatory prospects the analyst tells investors in a research note. The firm says the deal also extends the company's cash runway into 2026. Opco sees U.S. approval and launch by late 2025 and forecasts 2030 sales of"  
[X Link](https://x.com/zohmbastic/status/1836134956764127701)  2024-09-17T20:07Z 9414 followers, 4388 engagements


"$WAY 18M shs offering JPMorgan underwriter will add more if big pull"  
[X Link](https://x.com/zohmbastic/status/1965879524165562406)  2025-09-10T20:46Z 9414 followers, 3071 engagements


"$IOT back to 40s"  
[X Link](https://x.com/zohmbastic/status/1975260482555813905)  2025-10-06T18:02Z 9414 followers, 3381 engagements


"$DBRG 🙃 @Maximus_Holla @Sandman7591"  
[X Link](https://x.com/zohmbastic/status/1978127984537083928)  2025-10-14T15:57Z 9414 followers, 5436 engagements


"$DBRG quite some spread trades"  
[X Link](https://x.com/zohmbastic/status/1978173307934363718)  2025-10-14T18:57Z 9414 followers, 2967 engagements


"$DBRG OpenAI Oracle and Vantage Data Centers a leading global provider of hyperscale data center campuses today announced plans to develop a data center campus outside Milwaukee in Port Washington Wisconsin. The new campus is part of OpenAI and Oracles previously announced partnership to invest up to XXX gigawatts of additional Stargate capacity and is the Midwest site that was recently announced as part of OpenAIs Stargate expansion"  
[X Link](https://x.com/zohmbastic/status/1981089818789704179)  2025-10-22T20:06Z 9414 followers, 3911 engagements


"$NMRA PT fyi Guggenheim XX Needham X from X Guggenheim upgraded Neumora Therapeutics to Buy from Neutral with a $XX price target following the "compelling" preclinical obesity data reported by the company. The firm views the company's NLRP3i program in obesity and related disorders as "a clear driver to value creation" the analyst tells investors"  
[X Link](https://x.com/zohmbastic/status/1983679339318124900)  2025-10-29T23:36Z 9394 followers, 6923 engagements


"$MLCO ww especially after regular session open Casino sector doing well has presence in Asia quite positive looking ER # across Macau Cyprus Philliphines region. Melco Resorts and Enter Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $1.309B Beat $1.282B Estimate"  
[X Link](https://x.com/zohmbastic/status/1986429486317875642)  2025-11-06T13:44Z 9397 followers, 4732 engagements


"$CHYM XX holla"  
[X Link](https://x.com/zohmbastic/status/1986863075409133895)  2025-11-07T18:27Z 9394 followers, 1451 engagements


"$TVTX break"  
[X Link](https://x.com/zohmbastic/status/1988299545047167050)  2025-11-11T17:35Z 9408 followers, 2506 engagements


"$PERI decent er # ww on pull"  
[X Link](https://x.com/zohmbastic/status/1988586238090334552)  2025-11-12T12:34Z 9397 followers, 1967 engagements


"$GFS GLOBALFOUNDRIES Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $1.688B Beat $1.676B Estimate / GLOBALFOUNDRIES Sees Q4 Adj EPS $0.42-$0.52 vs $XXXX Est; Sees Sales $1.775B-$1.825B vs $1.794B Est"  
[X Link](https://x.com/zohmbastic/status/1988588132191846711)  2025-11-12T12:42Z 9396 followers, XXX engagements


"$RVMD lazy river"  
[X Link](https://x.com/zohmbastic/status/1988641524561989752)  2025-11-12T16:14Z 9406 followers, 3213 engagements


"$MLTX Deep Track 13G 4.6M XXXX %"  
[X Link](https://x.com/zohmbastic/status/1988714556311695824)  2025-11-12T21:04Z 9394 followers, 5298 engagements


"$MDGL Canaccord raised the firm's price target on Madrigal Pharmaceuticals to $XXX from $XXX and keeps a Buy rating on the shares. The firm updated its model to reflec the impending launch of Rezdiffra in the EU as well as coming out of 3Q earnings"  
[X Link](https://x.com/zohmbastic/status/1988952437173154113)  2025-11-13T12:49Z 9392 followers, 2507 engagements


"$AMRX Amneal Receives U.S. FDA Approval for Iohexol Injection"  
[X Link](https://x.com/zohmbastic/status/1989077030688920014)  2025-11-13T21:04Z 9388 followers, 1916 engagements


"Frazier : $ABVX $AKRO $ASMB $AURA $CBIO $CYTK $ENGN $EOLS $JBIO $TVTX $VALN"  
[X Link](https://x.com/zohmbastic/status/1989388931087867962)  2025-11-14T17:44Z 9395 followers, 4132 engagements


"Ecor1 $ALKS $AQST $BBIO $CNTA $CMPS $PEPG"  
[X Link](https://x.com/zohmbastic/status/1989389107253084640)  2025-11-14T17:44Z 9392 followers, 3915 engagements


"$SG locked a few"  
[X Link](https://x.com/zohmbastic/status/1989390894681002108)  2025-11-14T17:52Z 9392 followers, 3138 engagements


"Cormorant: $AMLX $BBIO $CABA $ORKA"  
[X Link](https://x.com/zohmbastic/status/1989395293566357606)  2025-11-14T18:09Z 9392 followers, 3150 engagements


"DEFNA: $CLDX $CMPX $INSP $MBX $NKTR $OBIO $RAPP $SLNO"  
[X Link](https://x.com/zohmbastic/status/1989407327833997643)  2025-11-14T18:57Z 9394 followers, 1019 engagements


"$SRPT Sarepta Therapeutics Inc. (NASDAQ:SRPT) the leader in precision genetic medicine for rare diseases today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl) the only approved gene therapy for Duchenne muscular dystrophy (DMD). As previously disclosed the ELEVIDYS label now includes several key updates including: A boxed warning for the risk of acute serious liver injury (ALI) and acute liver failure (ALF). The non-ambulatory indication has been removed from the Indication and Usage section of the Prescribing Information. The Company"  
[X Link](https://x.com/zohmbastic/status/1989421758126981425)  2025-11-14T19:54Z 9396 followers, 2383 engagements


"OPaleye: $ADCT $ALKS $ALMS $ACOG $ANNX $APGE $CABA $PLX $RVMD $RIGL $SRPT $SLGL $SYRE $TMCI"  
[X Link](https://x.com/zohmbastic/status/1989440858299462016)  2025-11-14T21:10Z 9397 followers, 1128 engagements


"Baker Bros: $ABVX $AGIO $ACLX $ARWR $RNA $ONC $CDTX $CRNX $CTMX $HRTX $DNTH $LBRX $MBX $NUVL $PHVX $RAPP $SYRE $VTYX $VKTX $VYNE etc"  
[X Link](https://x.com/zohmbastic/status/1989446851771449598)  2025-11-14T21:34Z 9414 followers, 15.6K engagements


"$NCLH Wells Fargo analyst Trey Bowers initiated coverage of Norwegian Cruise Line with an Overweight rating and $XX price target. The firm views the selloff in the shares post the Q3 report as a buying opportunity. Norwegian should grow earnings at a double-digit rate for years to come the analyst tells investors in a research note"  
[X Link](https://x.com/zohmbastic/status/1990530005130973575)  2025-11-17T21:18Z 9396 followers, 1236 engagements


"$MLTX decent intra block today"  
[X Link](https://x.com/zohmbastic/status/1990815968310833413)  2025-11-18T16:14Z 9392 followers, 1303 engagements


"$IMMX intra vol pop"  
[X Link](https://x.com/zohmbastic/status/1990860027775590830)  2025-11-18T19:09Z 9394 followers, 3172 engagements


"$GH 10min after posting looks like there was a massive vol came in not sure if there was any news maybe $EXAS effect"  
[X Link](https://x.com/zohmbastic/status/1991247630282731782)  2025-11-19T20:50Z 9414 followers, 5040 engagements


"$RVMD locked 1/2 today remaining will stop below 66ish"  
[X Link](https://x.com/zohmbastic/status/1991535526969765997)  2025-11-20T15:54Z 9394 followers, 2682 engagements


"$SG hit 6.6s today"  
[X Link](https://x.com/zohmbastic/status/1991933776247869592)  2025-11-21T18:16Z 9414 followers, 3231 engagements


"$AMTM Annual Revenues of $XXXX billion X% growth on a pro forma basis Annual Net Income of $XX million; Annual Adjusted EBITDA of $1104 million Annual Diluted Earnings Per Share of $0.27; Annual Adjusted Diluted Earnings Per Share of $XXXX Annual Operating Cash Flow of $XXX million; Annual Free Cash Flow of $XXX million Backlog of $XX billion; Book-to-Bill 1.6x Fourth Quarter 1.2x Full Year Reduced Net Debt to $XXX billion and Net Leverage to 3.2x"  
[X Link](https://x.com/zohmbastic/status/1993070347433001233)  2025-11-24T21:32Z 9392 followers, 2893 engagements


"$GRAL Farallon 2.18M 5.5%"  
[X Link](https://x.com/zohmbastic/status/1993121111635378200)  2025-11-25T00:54Z 9408 followers, 1970 engagements


"$GAP 25c decent so far too"  
[X Link](https://x.com/zohmbastic/status/1993384831548522729)  2025-11-25T18:22Z 9394 followers, 2142 engagements


"$ANVS will prob lock a few"  
[X Link](https://x.com/zohmbastic/status/1993389002859413704)  2025-11-25T18:39Z 9408 followers, 3209 engagements


"$RVMD weekly"  
[X Link](https://x.com/zohmbastic/status/1993396082781700111)  2025-11-25T19:07Z 9406 followers, 1398 engagements


"$ANF JPMorgan analyst Matthew Boss raised the firm's price target on Abercrombie & Fitch to $XXX from $XX and keeps a Neutral rating on the shares. The firm updated the company's model following the Q3 earnings beat"  
[X Link](https://x.com/zohmbastic/status/1993652638085500985)  2025-11-26T12:06Z 9414 followers, 2125 engagements


"$ANF UBS raised the firm's price target on Abercrombie & Fitch to $XXX from $XXX and keeps a Buy rating on the shares. Abercrombie & Fitch's Q3 sales beat and improved guidance highlight its strong fundamentals the analyst tells investors in a research note. UBS sees potential for an EPS compound annual growth rate of XX% following FY25"  
[X Link](https://x.com/zohmbastic/status/1993661891005084030)  2025-11-26T12:43Z 9414 followers, 2279 engagements


"$GAP testing res"  
[X Link](https://x.com/zohmbastic/status/1993706342503342395)  2025-11-26T15:40Z 9394 followers, 2208 engagements


"$EQX another gold name along with $B"  
[X Link](https://x.com/zohmbastic/status/1993755202219069864)  2025-11-26T18:54Z 9389 followers, XXX engagements


"$GAP nearing 28"  
[X Link](https://x.com/zohmbastic/status/1993768936031064337)  2025-11-26T19:48Z 9394 followers, 1112 engagements


"$ACVA decent vol pop"  
[X Link](https://x.com/zohmbastic/status/1993783555701510625)  2025-11-26T20:46Z 9389 followers, 2339 engagements


"$OMER Omeros Corporation (Nasdaq: OMER) today announced the closing of the asset sale and licensing transaction between Omeros and Novo Nordisk for the candidate drug zaltenibart (formerly OMS906). Zaltenibart is a first-in-class late-stage clinical humanized monoclonal antibody targeting MASP-3 the most upstream and key activator of the alternative pathway of the complement system and has shown multiple potential advantages over other alternative pathway inhibitors in development or on the market. The transaction was completed pursuant to an asset purchase and license agreement that was"  
[X Link](https://x.com/zohmbastic/status/1995485765971705929)  2025-12-01T13:30Z 9395 followers, 2739 engagements


"$ACVA nearing 8"  
[X Link](https://x.com/zohmbastic/status/1995507461575614504)  2025-12-01T14:57Z 9389 followers, 1118 engagements


"$ANVS stopped out will revisit"  
[X Link](https://x.com/zohmbastic/status/1995551700166353118)  2025-12-01T17:52Z 9396 followers, 1988 engagements


"$RKT intra highs don't forget $UWMC"  
[X Link](https://x.com/zohmbastic/status/1995591547279278251)  2025-12-01T20:31Z 9395 followers, 1717 engagements


"$ADMA strong eod"  
[X Link](https://x.com/zohmbastic/status/1995597648863396190)  2025-12-01T20:55Z 9396 followers, 2413 engagements


"$SLP Simulations Plus Q4 Adj. EPS $XXXX Beats $(0.05) Estimate Sales $17.500M Beat $17.095M Estimate / Simulations Plus Affirms FY2026 Adj EPS Guidance of $1.03-$1.10 vs $(3.22) Est; Affirms FY2026 Sales Guidance of $79.000M-$82.000M vs $78.797M Est"  
[X Link](https://x.com/zohmbastic/status/1995602271271559312)  2025-12-01T21:13Z 9405 followers, 2084 engagements


"$GH Morgan Stanley analyst Tejas Savant assumed coverage of Guardant Health with an Overweight rating and a price target of $XXX up from $XXX. Life Science Tools and Diagnostics end market bright spots are beginning to emerge and the firm sees "plenty of catalysts" in the pipeline across its coverage adding that it sees "lots to like in the space entering 2026." However a recent industry valuation spike in the second half of the year leaves multiples in "a fair place" so the firm starts the group with an In-Line industry view the analyst tells investors. Among the group the analyst identifies"  
[X Link](https://x.com/zohmbastic/status/1995607199369085315)  2025-12-01T21:33Z 9414 followers, 2067 engagements


"$KURA Kura Oncology Inc. (Nasdaq: KURA Kura) a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer today announced the first U.S. commercial sale of KOMZIFTI (ziftomenib) has been completed. Under Kuras collaboration and license agreement with Kyowa Kirin Co. Ltd. and Kyowa Kirin Inc. (collectively Kyowa Kirin) this milestone triggers a $XXX million payment from Kyowa Kirin to Kura which Kura expects to receive prior to year-end. KOMZIFTI was approved by the U.S. Food and Drug Administration on November XX 2025"  
[X Link](https://x.com/zohmbastic/status/1995841955180286032)  2025-12-02T13:06Z 9397 followers, 1634 engagements


"$ADMA weekly prob XX break setup soon"  
[X Link](https://x.com/zohmbastic/status/1995885177659425073)  2025-12-02T15:58Z 9397 followers, 2399 engagements


"$CMCSA COMCAST ON MONDAY MADE A RENEWED OFFER FOR PART OF WARNER BROS. THAT WOULD GIVE IT CONTROL OF THE COMBINED ENTITY - BLOOMBERG NEWS UNDER COMCAST OFFER WARNER BROS SHAREHOLDERS WOULD RECEIVE A COMBINATION OF CASH AND STOCK IN THE NEW ENTITY- BLOOMBERG NEWS"  
[X Link](https://x.com/zohmbastic/status/1995929709335789953)  2025-12-02T18:54Z 9395 followers, 6408 engagements


"$GTLB Total revenue of $XXXXX million up XX% year-over-year GAAP operating margin of (5)%; non-GAAP operating margin of XX% Operating cash flow of $XXXX million and non-GAAP adjusted free cash flow of $XXXX million GitLab Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $244.353M Beat $239.634M Estimate"  
[X Link](https://x.com/zohmbastic/status/1995963081126490571)  2025-12-02T21:07Z 9409 followers, 1365 engagements


"$AEO American Eagle Outfitters Q3 EPS $XXXX Beats $XXXX Estimate Sales $1.363B Beat $1.323B Estimate American Eagle Raises Q4 Operating Income Guidance To $155M$160M"  
[X Link](https://x.com/zohmbastic/status/1995964994400518530)  2025-12-02T21:15Z 9389 followers, 1602 engagements


"$GEV U.S. DEPARTMENT OF ENERGY ANNOUNCES $XXX MILLION IN FUNDING TO ACCELERATE DEPLOYMENT OF THE NATIONS FIRST COMMERCIAL SMALL MODULAR NUCLEAR REACTOR GE VERNOVA: US DOE'S GRANT IS TO THE TENNESSEE VALLEY AUTHORITY TO ACCELERATE DEPLOYMENT OF GE VERNOVA HITACHI'S BWRX-300 SMALL MODULAR REACTOR"  
[X Link](https://x.com/zohmbastic/status/1995979783868747942)  2025-12-02T22:13Z 9395 followers, 1484 engagements


"$AEO upgrades BofA XX from XX UBS XX from XX Citi XX from XX Barclays XX from XX JPMorgan XX from 14"  
[X Link](https://x.com/zohmbastic/status/1996194663427113397)  2025-12-03T12:27Z 9389 followers, 2642 engagements


"$AA nearing 44"  
[X Link](https://x.com/zohmbastic/status/1996240400818844134)  2025-12-03T15:29Z 9414 followers, XXX engagements


"$adma finally 20s"  
[X Link](https://x.com/zohmbastic/status/1996297206916129223)  2025-12-03T19:15Z 9396 followers, 1313 engagements


"$PATH UiPath Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $411.113M Beat $392.967M Estimate / UiPath Sees Q4 Sales $462.000M-$467.000M vs $462.909M Est"  
[X Link](https://x.com/zohmbastic/status/1996326674154283279)  2025-12-03T21:12Z 9394 followers, 7933 engagements


"$KALA XXXX hit locked a few 1.2s"  
[X Link](https://x.com/zohmbastic/status/1996367101066649623)  2025-12-03T23:53Z 9395 followers, 3106 engagements


"$PATH Canaccord XX from XX Wells Fargo XX from XX Barclays XX from XX Mizuho XX from XX Evercore XX from XX Evercore ISI raised the firm's price target on UiPath to $XX from $XX and keeps an In Line rating on the shares after the company delivered what the firm describes as "solid" fiscal Q3 results that showcase early momentum in AI and agentic automation. The company surpassed expectations for ARR revenue and operating margins while management's constructive tone highlighted strong customer engagement and expanding deployments the analyst tells investors in a post-earnings note"  
[X Link](https://x.com/zohmbastic/status/1996570044784902584)  2025-12-04T13:19Z 9395 followers, 1529 engagements


"$TIGR UP Fintech: Quarterly Revenue and Profit Hit Record High; Global Client Assets Reach US$61 Billion UP Fintech Holding Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $153.218M Beat $128.150M Estimate"  
[X Link](https://x.com/zohmbastic/status/1996571538535915874)  2025-12-04T13:25Z 9407 followers, XXX engagements


"$TGT TARGET TESTS NEW MODELS FOR NEXT-DAY DELIVERY - WSJ"  
[X Link](https://x.com/zohmbastic/status/1996645529590386909)  2025-12-04T18:19Z 9394 followers, XXX engagements


"$SFIX Stitch Fix Q1 EPS $(0.05) Beats $(0.06) Estimate Sales $342.127M Beat $335.832M Estimate / Stitch Fix Sees Q2 Sales $335.000M-$340.000M vs $301.887M Est / Stitch Fix Raises FY2026 Sales Guidance from $1.280B-$1.330B to $1.320B-$1.350B vs $1.303B Est"  
[X Link](https://x.com/zohmbastic/status/1996689345110016167)  2025-12-04T21:13Z 9394 followers, 1755 engagements


"$SOFI SoFi Technologies Inc. (NASDAQ: SOFI) (SoFi or the Company) today announced an underwritten public offering of $XXX billion of shares of its common stock. In connection with the offering SoFi expects to grant the underwriter a 30-day option to purchase up to an additional XX% of the shares of common stock offered in the offering. All of the shares of common stock in the offering will be sold by SoFi. SoFi intends to use the net proceeds from the offering for general corporate purposes including but not limited to enhancing capital position increasing optionality and enabling further"  
[X Link](https://x.com/zohmbastic/status/1996690555447734375)  2025-12-04T21:18Z 9395 followers, 3229 engagements


"$MP Morgan Stanley upgraded MP Materials to Overweight from Equal Weight with a price target of $XX up from $XXXXX. The firm says China's one-year pause on rare earth restrictions does not solve the U.S.'s critical mineral dependency issues. MP is positioned to benefit as the U.S. looks to develop a robust supply chain outside of China the analyst tells investors in a research note. Morgan Stanley sees potential for more commercial deals to be announced as magnet users diversify"  
[X Link](https://x.com/zohmbastic/status/1996916732510789980)  2025-12-05T12:17Z 9406 followers, 3004 engagements


"$VSCO Victoria's Secret Sees FY2025 Adj EPS $2.40-$2.65 vs $XXXX Est; Raises FY2025 Sales Guidance from $6.330B-$6.410B to $6.450B-$6.480B vs $6.389B Est"  
[X Link](https://x.com/zohmbastic/status/1996917295369588959)  2025-12-05T12:19Z 9394 followers, 3455 engagements


"$QCOM not bad trend"  
[X Link](https://x.com/zohmbastic/status/1996959501505675744)  2025-12-05T15:07Z 9396 followers, 1198 engagements


"$VSCO wen 50"  
[X Link](https://x.com/zohmbastic/status/1996959833812029830)  2025-12-05T15:08Z 9394 followers, 1814 engagements


"$DBRG buyout chatter Softbank halted up"  
[X Link](https://x.com/zohmbastic/status/1996961348480078071)  2025-12-05T15:14Z 9414 followers, 3345 engagements


"$VTYX starting to bnce some March spreaders"  
[X Link](https://x.com/zohmbastic/status/1996962719719628923)  2025-12-05T15:19Z 9414 followers, 2387 engagements


"$CNX Jan 38c large sweep"  
[X Link](https://x.com/zohmbastic/status/1996985685954171293)  2025-12-05T16:51Z 9397 followers, XXX engagements


"$PATH for now will prob exercise a few weekly 14.5c and trim some 17.5c eod"  
[X Link](https://x.com/zohmbastic/status/1997026307700646386)  2025-12-05T19:32Z 9397 followers, 2670 engagements


"$JNJ Johnson & Johnson's INLEXZO (gemcitabine intravesical system) delivers XX percent disease-free survival at one year in BCG-unresponsive high-risk papillary-only NMIBC"  
[X Link](https://x.com/zohmbastic/status/1997053624447345030)  2025-12-05T21:21Z 9395 followers, 1051 engagements


"$IDYA On December X 2025 GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) (GSK) communicated to IDEAYA Biosciences Inc. (the Company) its election to terminate the Collaboration Option and License Agreement dated June XX 2020 (as amended the Agreement). Pursuant to the terms of the Agreement such termination will be effective ninety (90) days following the date of GSKs written notice. During the ninety-day transition period GSK will transfer the Werner Helicase (IDE275) and Pol Theta (IDE705) clinical programs to the Company in accordance with the applicable provisions of the Agreement. The"  
[X Link](https://x.com/zohmbastic/status/1997055138213556559)  2025-12-05T21:27Z 9414 followers, 1446 engagements


"Farallon: $ABVX $ALE $ALNY $AMZN $ASMB $BIDU $ONC $BCRX $CDTX $DOCS $LLY $GRAL $GH $ICLR $NTLA $IONS $K $MRUS $MLYS $MIRM etc"  
[X Link](https://x.com/zohmbastic/status/1989371736853512503)  2025-11-14T16:35Z 9414 followers, 2044 engagements


"$VSCO JPMorgan analyst Matthew Boss upgraded Victoria's Secret to Overweight from Neutral with a price target of $XX up from $XX following the Q3 report. The stock in afternoon trading is up XX% or $XXXX to $XXXXX. A an earnings and sales "inflection" is underway at Victoria's the analyst tells investors in a research note. JPMorgan sees $XXXX in fiscal 2027 earnings per share power as a "base-case" based on "consistent" low- to mid-single-digit same-store-sales growth. It believes the company is seeing momentum into the holiday"  
[X Link](https://x.com/zohmbastic/status/1997017278626320403)  2025-12-05T18:56Z 9411 followers, 2564 engagements


"$PATH weekly"  
[X Link](https://x.com/zohmbastic/status/1998038712433979736)  2025-12-08T14:35Z 9415 followers, 2319 engagements


"$GDS got starter size today chinese data center name considering situation Trump vs Xi re:$NVDA H200 chips may see future boost in server infrastructure in terms of power and space. will add more on pull risk 30-31 zone"  
[X Link](https://x.com/zohmbastic/status/1998458897279996035)  2025-12-09T18:25Z 9415 followers, XXX engagements


"$U Needham and Wedbush PT XX almost there"  
[X Link](https://x.com/zohmbastic/status/1998477223825911887)  2025-12-09T19:37Z 9415 followers, 1057 engagements


"$RKT Rocket Companies Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $1.783B Beat $1.668B Estimate"  
[X Link](https://x.com/zohmbastic/status/1983989596859068555)  2025-10-30T20:09Z 9409 followers, 10.7K engagements


"$TVTX U.S. net product sales of FILSPARI (sparsentan) grew XXX% year-over-year to $XXXX million in 3Q 2025; XXX new PSFs received during the quarter Total revenue for 3Q 2025 was $XXXXX million including U.S. net product sales of $XXXXX million Retired remaining $XX million of 2025 convertible notes and achieved $XX million EU market access milestone further strengthening financial foundation 2025 KDIGO guidelines and streamlined REMS monitoring strengthen FILSPARIs position as a foundational nephroprotective therapy for IgAN Company well-positioned for potential FDA approval and commercial"  
[X Link](https://x.com/zohmbastic/status/1983993393781903817)  2025-10-30T20:24Z 9411 followers, 16.8K engagements


"$RKT As previously reported Oppenheimer analyst Chad Larkin initiated coverage of Rocket Companies with an Outperform rating and $XX price target. The firm believes Rocket represents the best way to invest in residential real estate as rates fall and drive refinance demand. In addition after acquiring Redfin and Mr. Cooper Rocket has created the best top of funnel to capture and monetize the life cycle of real estate Oppenheimer says. While the firm expects purchase demand to remain weak as affordability continues to be challenged refinance demand will increase if mortgage rates continue to"  
[X Link](https://x.com/zohmbastic/status/1988951485883830610)  2025-11-13T12:46Z 9409 followers, 3618 engagements


"$NUVB strong eod"  
[X Link](https://x.com/zohmbastic/status/1996322520710959483)  2025-12-03T20:55Z 9410 followers, 1363 engagements


"$SNPS $NVDA NVIDIA and Synopsys Announce Strategic Partnership to Revolutionize Engineering and Design"  
[X Link](https://x.com/zohmbastic/status/1995479107216257508)  2025-12-01T13:04Z 9415 followers, 2996 engagements


"$AEO AEO Total revenue increased X% to a record $XXX billion driven by total comparable sales increase of X% with positive results across brands Aerie comps +11% American Eagle comps +1% Momentum continues raises fourth quarter operating income guidance to $XXX to $XXX million on comp growth of X% to 9%"  
[X Link](https://x.com/zohmbastic/status/1995963953831149803)  2025-12-02T21:11Z 9412 followers, 4010 engagements


"$VSCO hitting 50s"  
[X Link](https://x.com/zohmbastic/status/1998115558987079965)  2025-12-08T19:40Z 9411 followers, 1205 engagements


"$TVTX intra block today"  
[X Link](https://x.com/zohmbastic/status/1998126646268924074)  2025-12-08T20:24Z 9415 followers, 1322 engagements


"$RLMD holding well"  
[X Link](https://x.com/zohmbastic/status/1998404854490808762)  2025-12-09T14:50Z 9415 followers, XXX engagements


"$SG decent come back one of sqz candidates"  
[X Link](https://x.com/zohmbastic/status/1998454286200504462)  2025-12-09T18:06Z 9415 followers, 1210 engagements


"$TVTX flaggy"  
[X Link](https://x.com/zohmbastic/status/1993015348845855007)  2025-11-24T17:54Z 9414 followers, 2473 engagements


"$TE Alliance Global analyst Jake Sekelsky initiated coverage of T1 Energy with a Buy rating and $XXXX price target. The firm believes T1 is positioned to become a leading vertically integrated solar manufacturer. The company will serve as a "key player" in securing the broader solar supply chain in the United States the analyst tells investors in a research note. Alliance says current share price levels "represent an attractive entry point ahead of a catalyst-rich 2026.""  
[X Link](https://x.com/zohmbastic/status/1998374759160033567)  2025-12-09T12:50Z 9415 followers, 3213 engagements


"$WRBY watching for continuation"  
[X Link](https://x.com/zohmbastic/status/1998402631958446251)  2025-12-09T14:41Z 9415 followers, 2037 engagements


"$APGE Deutsche Bank initiated coverage of Apogee Therapeutics with a Buy rating and $XXX price target"  
[X Link](https://x.com/zohmbastic/status/1998531223782830185)  2025-12-09T23:12Z 9415 followers, 2159 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@zohmbastic Avatar @zohmbastic zohm

No specific company named "zohm" appears in the provided tweets. However, various companies are trending with updates on earnings, analyst upgrades and downgrades, and new partnerships. Some companies like $MARa, $FIVE, and $RLX reported strong quarterly earnings.

Engagements: XXXXXX #

Engagements Line Chart

  • X Week XXXXXXX -XX%
  • X Month XXXXXXXXX -XX%
  • X Months XXXXXXXXXX +179%
  • X Year XXXXXXXXXX +223%

Mentions: XX #

Mentions Line Chart

  • X Week XXX -XX%
  • X Month XXXXX -XX%
  • X Months XXXXX +110%
  • X Year XXXXX +180%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.72%
  • X Month XXXXX +2.20%
  • X Months XXXXX +27%
  • X Year XXXXX +54%

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% cryptocurrencies XXXX% finance XXXX% countries XXXX% technology brands XXXX% fashion brands XXXX% exchanges XXXX%

Social topic influence target #827, strong 2.36%, price target #20, $dbrg #21, $sg #3, morgan stanley #29, $tvtx #9, $rvmd #23, $acva 1.68%, $gh #15

Top accounts mentioned or mentioned by @maximusholla @sandman7591 @pnani456 @jefftheomega1 @hannibalspeaks @doepkemichel @stocktalkweekly @margaret252384 @joserestonva @almightyzeeza @josericaurtej @marketprophit @traderjon01 @boxlongs @tagthatstock @byebyegoodguy @fabiomclean @fd_coop_ny

Top assets mentioned DigitalBridge Group, Inc. (DBRG) Sweetgreen, Inc. (SG) Morgan Stanley (MS) Travere Therapeutics, Inc. Common Stock (TVTX) Revolution Medicines, Inc. Common Stock (RVMD) ACV Auctions Inc. Class A Common Stock (ACVA) Guardant Health, Inc. Common Stock (GH) UiPath, Inc. (PATH) Victoria's Secret & Co. (VSCO) NVIDIA Corp. (NVDA) ADMA Biologics, Inc. (ADMA) Rocket Companies, Inc. (RKT) American Eagle Outfitters (AEO) Helium IOT (IOT) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Apogee Therapeutics, Inc. Common Stock (APGE) Exact Sciences Corp (EXAS) Gapcoin (GAP-1) A3S Protocol (AA) Applied Blockchain, Inc. Common Stock (APLD) Waystar Holding Corp. Common Stock (WAY) PERI Finance (PERI) Cytokinetics Inc. (CYTK) Alkermes Inc. plc (ALKS) BridgeBio Pharma, Inc. Common Stock (BBIO) Marblex (MBX) Sarepta Therapeutics, Inc. (SRPT) Arrowhead Research Corporation (ARWR) One Cash (ONC) Cidara Therapeutics, Inc. (CDTX) Viking Therapeutics, Inc (VKTX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) GRAIL, Inc. Common Stock (GRAL) Abercrombie & Fitch Co. (ANF) Smooth Love Potion (SLP) Warby Parker Inc. (WRBY) Terns Pharmaceuticals, Inc. Common Stock (TERN) Advanced Micro Devices (AMD) Intel Corporation (INTC) Neumora Therapeutics, Inc. Common Stock (NMRA) Chime Financial, Inc. Class A Common Stock (CHYM) GlobalFoundries, Inc. (GFS)

Top Social Posts

Top posts by engagements in the last XX hours

"$RLMD hit 5"
X Link 2025-11-19T14:39Z 9414 followers, 2057 engagements

"$NVDA TRUMP: UNITED STATES WILL ALLOW NVIDIA TO SHIP ITS H200 PRODUCTS TO APPROVED CUSTOMERS IN CHINA AND OTHER COUNTRIES"
X Link 2025-12-08T21:31Z 9411 followers, 2593 engagements

"$TERN upgrades HCW XX from XX Mizuho XX from XX Truist XX from XX BMO Capital XX from XX Barclays XX from 36"
X Link 2025-12-09T12:49Z 9414 followers, 2638 engagements

"$BMEA BMEA Biomea Fusion Reports Durable Glycemic And C-Peptide Improvements X Months After Last Dose In COVALENT-111 With Icovamenib"
X Link 2025-12-05T13:29Z 9415 followers, 2945 engagements

"$NVDA $AMD $INTC TRUMP: SAME APPROACH WILL APPLY TO AMD INTEL AND OTHER GREAT AMERICAN COMPANIES"
X Link 2025-12-08T21:33Z 9411 followers, 1587 engagements

"$APLD 28c deep ITM + 500%"
X Link 2025-12-09T16:09Z 9414 followers, 1366 engagements

"$CAPR Oppenheimer raised the firm's price target on Capricor Therapeutics to $XX from $XX and keeps an Outperform rating on the shares. Today's announcement that binding terms for deramiocel's European commercialization have been agreed upon with partner Nippon Shinyaku gives Capricor access to another leading pharmaceutical market and signals third-party confidence in global regulatory prospects the analyst tells investors in a research note. The firm says the deal also extends the company's cash runway into 2026. Opco sees U.S. approval and launch by late 2025 and forecasts 2030 sales of"
X Link 2024-09-17T20:07Z 9414 followers, 4388 engagements

"$WAY 18M shs offering JPMorgan underwriter will add more if big pull"
X Link 2025-09-10T20:46Z 9414 followers, 3071 engagements

"$IOT back to 40s"
X Link 2025-10-06T18:02Z 9414 followers, 3381 engagements

"$DBRG 🙃 @Maximus_Holla @Sandman7591"
X Link 2025-10-14T15:57Z 9414 followers, 5436 engagements

"$DBRG quite some spread trades"
X Link 2025-10-14T18:57Z 9414 followers, 2967 engagements

"$DBRG OpenAI Oracle and Vantage Data Centers a leading global provider of hyperscale data center campuses today announced plans to develop a data center campus outside Milwaukee in Port Washington Wisconsin. The new campus is part of OpenAI and Oracles previously announced partnership to invest up to XXX gigawatts of additional Stargate capacity and is the Midwest site that was recently announced as part of OpenAIs Stargate expansion"
X Link 2025-10-22T20:06Z 9414 followers, 3911 engagements

"$NMRA PT fyi Guggenheim XX Needham X from X Guggenheim upgraded Neumora Therapeutics to Buy from Neutral with a $XX price target following the "compelling" preclinical obesity data reported by the company. The firm views the company's NLRP3i program in obesity and related disorders as "a clear driver to value creation" the analyst tells investors"
X Link 2025-10-29T23:36Z 9394 followers, 6923 engagements

"$MLCO ww especially after regular session open Casino sector doing well has presence in Asia quite positive looking ER # across Macau Cyprus Philliphines region. Melco Resorts and Enter Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $1.309B Beat $1.282B Estimate"
X Link 2025-11-06T13:44Z 9397 followers, 4732 engagements

"$CHYM XX holla"
X Link 2025-11-07T18:27Z 9394 followers, 1451 engagements

"$TVTX break"
X Link 2025-11-11T17:35Z 9408 followers, 2506 engagements

"$PERI decent er # ww on pull"
X Link 2025-11-12T12:34Z 9397 followers, 1967 engagements

"$GFS GLOBALFOUNDRIES Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $1.688B Beat $1.676B Estimate / GLOBALFOUNDRIES Sees Q4 Adj EPS $0.42-$0.52 vs $XXXX Est; Sees Sales $1.775B-$1.825B vs $1.794B Est"
X Link 2025-11-12T12:42Z 9396 followers, XXX engagements

"$RVMD lazy river"
X Link 2025-11-12T16:14Z 9406 followers, 3213 engagements

"$MLTX Deep Track 13G 4.6M XXXX %"
X Link 2025-11-12T21:04Z 9394 followers, 5298 engagements

"$MDGL Canaccord raised the firm's price target on Madrigal Pharmaceuticals to $XXX from $XXX and keeps a Buy rating on the shares. The firm updated its model to reflec the impending launch of Rezdiffra in the EU as well as coming out of 3Q earnings"
X Link 2025-11-13T12:49Z 9392 followers, 2507 engagements

"$AMRX Amneal Receives U.S. FDA Approval for Iohexol Injection"
X Link 2025-11-13T21:04Z 9388 followers, 1916 engagements

"Frazier : $ABVX $AKRO $ASMB $AURA $CBIO $CYTK $ENGN $EOLS $JBIO $TVTX $VALN"
X Link 2025-11-14T17:44Z 9395 followers, 4132 engagements

"Ecor1 $ALKS $AQST $BBIO $CNTA $CMPS $PEPG"
X Link 2025-11-14T17:44Z 9392 followers, 3915 engagements

"$SG locked a few"
X Link 2025-11-14T17:52Z 9392 followers, 3138 engagements

"Cormorant: $AMLX $BBIO $CABA $ORKA"
X Link 2025-11-14T18:09Z 9392 followers, 3150 engagements

"DEFNA: $CLDX $CMPX $INSP $MBX $NKTR $OBIO $RAPP $SLNO"
X Link 2025-11-14T18:57Z 9394 followers, 1019 engagements

"$SRPT Sarepta Therapeutics Inc. (NASDAQ:SRPT) the leader in precision genetic medicine for rare diseases today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl) the only approved gene therapy for Duchenne muscular dystrophy (DMD). As previously disclosed the ELEVIDYS label now includes several key updates including: A boxed warning for the risk of acute serious liver injury (ALI) and acute liver failure (ALF). The non-ambulatory indication has been removed from the Indication and Usage section of the Prescribing Information. The Company"
X Link 2025-11-14T19:54Z 9396 followers, 2383 engagements

"OPaleye: $ADCT $ALKS $ALMS $ACOG $ANNX $APGE $CABA $PLX $RVMD $RIGL $SRPT $SLGL $SYRE $TMCI"
X Link 2025-11-14T21:10Z 9397 followers, 1128 engagements

"Baker Bros: $ABVX $AGIO $ACLX $ARWR $RNA $ONC $CDTX $CRNX $CTMX $HRTX $DNTH $LBRX $MBX $NUVL $PHVX $RAPP $SYRE $VTYX $VKTX $VYNE etc"
X Link 2025-11-14T21:34Z 9414 followers, 15.6K engagements

"$NCLH Wells Fargo analyst Trey Bowers initiated coverage of Norwegian Cruise Line with an Overweight rating and $XX price target. The firm views the selloff in the shares post the Q3 report as a buying opportunity. Norwegian should grow earnings at a double-digit rate for years to come the analyst tells investors in a research note"
X Link 2025-11-17T21:18Z 9396 followers, 1236 engagements

"$MLTX decent intra block today"
X Link 2025-11-18T16:14Z 9392 followers, 1303 engagements

"$IMMX intra vol pop"
X Link 2025-11-18T19:09Z 9394 followers, 3172 engagements

"$GH 10min after posting looks like there was a massive vol came in not sure if there was any news maybe $EXAS effect"
X Link 2025-11-19T20:50Z 9414 followers, 5040 engagements

"$RVMD locked 1/2 today remaining will stop below 66ish"
X Link 2025-11-20T15:54Z 9394 followers, 2682 engagements

"$SG hit 6.6s today"
X Link 2025-11-21T18:16Z 9414 followers, 3231 engagements

"$AMTM Annual Revenues of $XXXX billion X% growth on a pro forma basis Annual Net Income of $XX million; Annual Adjusted EBITDA of $1104 million Annual Diluted Earnings Per Share of $0.27; Annual Adjusted Diluted Earnings Per Share of $XXXX Annual Operating Cash Flow of $XXX million; Annual Free Cash Flow of $XXX million Backlog of $XX billion; Book-to-Bill 1.6x Fourth Quarter 1.2x Full Year Reduced Net Debt to $XXX billion and Net Leverage to 3.2x"
X Link 2025-11-24T21:32Z 9392 followers, 2893 engagements

"$GRAL Farallon 2.18M 5.5%"
X Link 2025-11-25T00:54Z 9408 followers, 1970 engagements

"$GAP 25c decent so far too"
X Link 2025-11-25T18:22Z 9394 followers, 2142 engagements

"$ANVS will prob lock a few"
X Link 2025-11-25T18:39Z 9408 followers, 3209 engagements

"$RVMD weekly"
X Link 2025-11-25T19:07Z 9406 followers, 1398 engagements

"$ANF JPMorgan analyst Matthew Boss raised the firm's price target on Abercrombie & Fitch to $XXX from $XX and keeps a Neutral rating on the shares. The firm updated the company's model following the Q3 earnings beat"
X Link 2025-11-26T12:06Z 9414 followers, 2125 engagements

"$ANF UBS raised the firm's price target on Abercrombie & Fitch to $XXX from $XXX and keeps a Buy rating on the shares. Abercrombie & Fitch's Q3 sales beat and improved guidance highlight its strong fundamentals the analyst tells investors in a research note. UBS sees potential for an EPS compound annual growth rate of XX% following FY25"
X Link 2025-11-26T12:43Z 9414 followers, 2279 engagements

"$GAP testing res"
X Link 2025-11-26T15:40Z 9394 followers, 2208 engagements

"$EQX another gold name along with $B"
X Link 2025-11-26T18:54Z 9389 followers, XXX engagements

"$GAP nearing 28"
X Link 2025-11-26T19:48Z 9394 followers, 1112 engagements

"$ACVA decent vol pop"
X Link 2025-11-26T20:46Z 9389 followers, 2339 engagements

"$OMER Omeros Corporation (Nasdaq: OMER) today announced the closing of the asset sale and licensing transaction between Omeros and Novo Nordisk for the candidate drug zaltenibart (formerly OMS906). Zaltenibart is a first-in-class late-stage clinical humanized monoclonal antibody targeting MASP-3 the most upstream and key activator of the alternative pathway of the complement system and has shown multiple potential advantages over other alternative pathway inhibitors in development or on the market. The transaction was completed pursuant to an asset purchase and license agreement that was"
X Link 2025-12-01T13:30Z 9395 followers, 2739 engagements

"$ACVA nearing 8"
X Link 2025-12-01T14:57Z 9389 followers, 1118 engagements

"$ANVS stopped out will revisit"
X Link 2025-12-01T17:52Z 9396 followers, 1988 engagements

"$RKT intra highs don't forget $UWMC"
X Link 2025-12-01T20:31Z 9395 followers, 1717 engagements

"$ADMA strong eod"
X Link 2025-12-01T20:55Z 9396 followers, 2413 engagements

"$SLP Simulations Plus Q4 Adj. EPS $XXXX Beats $(0.05) Estimate Sales $17.500M Beat $17.095M Estimate / Simulations Plus Affirms FY2026 Adj EPS Guidance of $1.03-$1.10 vs $(3.22) Est; Affirms FY2026 Sales Guidance of $79.000M-$82.000M vs $78.797M Est"
X Link 2025-12-01T21:13Z 9405 followers, 2084 engagements

"$GH Morgan Stanley analyst Tejas Savant assumed coverage of Guardant Health with an Overweight rating and a price target of $XXX up from $XXX. Life Science Tools and Diagnostics end market bright spots are beginning to emerge and the firm sees "plenty of catalysts" in the pipeline across its coverage adding that it sees "lots to like in the space entering 2026." However a recent industry valuation spike in the second half of the year leaves multiples in "a fair place" so the firm starts the group with an In-Line industry view the analyst tells investors. Among the group the analyst identifies"
X Link 2025-12-01T21:33Z 9414 followers, 2067 engagements

"$KURA Kura Oncology Inc. (Nasdaq: KURA Kura) a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer today announced the first U.S. commercial sale of KOMZIFTI (ziftomenib) has been completed. Under Kuras collaboration and license agreement with Kyowa Kirin Co. Ltd. and Kyowa Kirin Inc. (collectively Kyowa Kirin) this milestone triggers a $XXX million payment from Kyowa Kirin to Kura which Kura expects to receive prior to year-end. KOMZIFTI was approved by the U.S. Food and Drug Administration on November XX 2025"
X Link 2025-12-02T13:06Z 9397 followers, 1634 engagements

"$ADMA weekly prob XX break setup soon"
X Link 2025-12-02T15:58Z 9397 followers, 2399 engagements

"$CMCSA COMCAST ON MONDAY MADE A RENEWED OFFER FOR PART OF WARNER BROS. THAT WOULD GIVE IT CONTROL OF THE COMBINED ENTITY - BLOOMBERG NEWS UNDER COMCAST OFFER WARNER BROS SHAREHOLDERS WOULD RECEIVE A COMBINATION OF CASH AND STOCK IN THE NEW ENTITY- BLOOMBERG NEWS"
X Link 2025-12-02T18:54Z 9395 followers, 6408 engagements

"$GTLB Total revenue of $XXXXX million up XX% year-over-year GAAP operating margin of (5)%; non-GAAP operating margin of XX% Operating cash flow of $XXXX million and non-GAAP adjusted free cash flow of $XXXX million GitLab Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $244.353M Beat $239.634M Estimate"
X Link 2025-12-02T21:07Z 9409 followers, 1365 engagements

"$AEO American Eagle Outfitters Q3 EPS $XXXX Beats $XXXX Estimate Sales $1.363B Beat $1.323B Estimate American Eagle Raises Q4 Operating Income Guidance To $155M$160M"
X Link 2025-12-02T21:15Z 9389 followers, 1602 engagements

"$GEV U.S. DEPARTMENT OF ENERGY ANNOUNCES $XXX MILLION IN FUNDING TO ACCELERATE DEPLOYMENT OF THE NATIONS FIRST COMMERCIAL SMALL MODULAR NUCLEAR REACTOR GE VERNOVA: US DOE'S GRANT IS TO THE TENNESSEE VALLEY AUTHORITY TO ACCELERATE DEPLOYMENT OF GE VERNOVA HITACHI'S BWRX-300 SMALL MODULAR REACTOR"
X Link 2025-12-02T22:13Z 9395 followers, 1484 engagements

"$AEO upgrades BofA XX from XX UBS XX from XX Citi XX from XX Barclays XX from XX JPMorgan XX from 14"
X Link 2025-12-03T12:27Z 9389 followers, 2642 engagements

"$AA nearing 44"
X Link 2025-12-03T15:29Z 9414 followers, XXX engagements

"$adma finally 20s"
X Link 2025-12-03T19:15Z 9396 followers, 1313 engagements

"$PATH UiPath Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $411.113M Beat $392.967M Estimate / UiPath Sees Q4 Sales $462.000M-$467.000M vs $462.909M Est"
X Link 2025-12-03T21:12Z 9394 followers, 7933 engagements

"$KALA XXXX hit locked a few 1.2s"
X Link 2025-12-03T23:53Z 9395 followers, 3106 engagements

"$PATH Canaccord XX from XX Wells Fargo XX from XX Barclays XX from XX Mizuho XX from XX Evercore XX from XX Evercore ISI raised the firm's price target on UiPath to $XX from $XX and keeps an In Line rating on the shares after the company delivered what the firm describes as "solid" fiscal Q3 results that showcase early momentum in AI and agentic automation. The company surpassed expectations for ARR revenue and operating margins while management's constructive tone highlighted strong customer engagement and expanding deployments the analyst tells investors in a post-earnings note"
X Link 2025-12-04T13:19Z 9395 followers, 1529 engagements

"$TIGR UP Fintech: Quarterly Revenue and Profit Hit Record High; Global Client Assets Reach US$61 Billion UP Fintech Holding Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $153.218M Beat $128.150M Estimate"
X Link 2025-12-04T13:25Z 9407 followers, XXX engagements

"$TGT TARGET TESTS NEW MODELS FOR NEXT-DAY DELIVERY - WSJ"
X Link 2025-12-04T18:19Z 9394 followers, XXX engagements

"$SFIX Stitch Fix Q1 EPS $(0.05) Beats $(0.06) Estimate Sales $342.127M Beat $335.832M Estimate / Stitch Fix Sees Q2 Sales $335.000M-$340.000M vs $301.887M Est / Stitch Fix Raises FY2026 Sales Guidance from $1.280B-$1.330B to $1.320B-$1.350B vs $1.303B Est"
X Link 2025-12-04T21:13Z 9394 followers, 1755 engagements

"$SOFI SoFi Technologies Inc. (NASDAQ: SOFI) (SoFi or the Company) today announced an underwritten public offering of $XXX billion of shares of its common stock. In connection with the offering SoFi expects to grant the underwriter a 30-day option to purchase up to an additional XX% of the shares of common stock offered in the offering. All of the shares of common stock in the offering will be sold by SoFi. SoFi intends to use the net proceeds from the offering for general corporate purposes including but not limited to enhancing capital position increasing optionality and enabling further"
X Link 2025-12-04T21:18Z 9395 followers, 3229 engagements

"$MP Morgan Stanley upgraded MP Materials to Overweight from Equal Weight with a price target of $XX up from $XXXXX. The firm says China's one-year pause on rare earth restrictions does not solve the U.S.'s critical mineral dependency issues. MP is positioned to benefit as the U.S. looks to develop a robust supply chain outside of China the analyst tells investors in a research note. Morgan Stanley sees potential for more commercial deals to be announced as magnet users diversify"
X Link 2025-12-05T12:17Z 9406 followers, 3004 engagements

"$VSCO Victoria's Secret Sees FY2025 Adj EPS $2.40-$2.65 vs $XXXX Est; Raises FY2025 Sales Guidance from $6.330B-$6.410B to $6.450B-$6.480B vs $6.389B Est"
X Link 2025-12-05T12:19Z 9394 followers, 3455 engagements

"$QCOM not bad trend"
X Link 2025-12-05T15:07Z 9396 followers, 1198 engagements

"$VSCO wen 50"
X Link 2025-12-05T15:08Z 9394 followers, 1814 engagements

"$DBRG buyout chatter Softbank halted up"
X Link 2025-12-05T15:14Z 9414 followers, 3345 engagements

"$VTYX starting to bnce some March spreaders"
X Link 2025-12-05T15:19Z 9414 followers, 2387 engagements

"$CNX Jan 38c large sweep"
X Link 2025-12-05T16:51Z 9397 followers, XXX engagements

"$PATH for now will prob exercise a few weekly 14.5c and trim some 17.5c eod"
X Link 2025-12-05T19:32Z 9397 followers, 2670 engagements

"$JNJ Johnson & Johnson's INLEXZO (gemcitabine intravesical system) delivers XX percent disease-free survival at one year in BCG-unresponsive high-risk papillary-only NMIBC"
X Link 2025-12-05T21:21Z 9395 followers, 1051 engagements

"$IDYA On December X 2025 GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) (GSK) communicated to IDEAYA Biosciences Inc. (the Company) its election to terminate the Collaboration Option and License Agreement dated June XX 2020 (as amended the Agreement). Pursuant to the terms of the Agreement such termination will be effective ninety (90) days following the date of GSKs written notice. During the ninety-day transition period GSK will transfer the Werner Helicase (IDE275) and Pol Theta (IDE705) clinical programs to the Company in accordance with the applicable provisions of the Agreement. The"
X Link 2025-12-05T21:27Z 9414 followers, 1446 engagements

"Farallon: $ABVX $ALE $ALNY $AMZN $ASMB $BIDU $ONC $BCRX $CDTX $DOCS $LLY $GRAL $GH $ICLR $NTLA $IONS $K $MRUS $MLYS $MIRM etc"
X Link 2025-11-14T16:35Z 9414 followers, 2044 engagements

"$VSCO JPMorgan analyst Matthew Boss upgraded Victoria's Secret to Overweight from Neutral with a price target of $XX up from $XX following the Q3 report. The stock in afternoon trading is up XX% or $XXXX to $XXXXX. A an earnings and sales "inflection" is underway at Victoria's the analyst tells investors in a research note. JPMorgan sees $XXXX in fiscal 2027 earnings per share power as a "base-case" based on "consistent" low- to mid-single-digit same-store-sales growth. It believes the company is seeing momentum into the holiday"
X Link 2025-12-05T18:56Z 9411 followers, 2564 engagements

"$PATH weekly"
X Link 2025-12-08T14:35Z 9415 followers, 2319 engagements

"$GDS got starter size today chinese data center name considering situation Trump vs Xi re:$NVDA H200 chips may see future boost in server infrastructure in terms of power and space. will add more on pull risk 30-31 zone"
X Link 2025-12-09T18:25Z 9415 followers, XXX engagements

"$U Needham and Wedbush PT XX almost there"
X Link 2025-12-09T19:37Z 9415 followers, 1057 engagements

"$RKT Rocket Companies Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $1.783B Beat $1.668B Estimate"
X Link 2025-10-30T20:09Z 9409 followers, 10.7K engagements

"$TVTX U.S. net product sales of FILSPARI (sparsentan) grew XXX% year-over-year to $XXXX million in 3Q 2025; XXX new PSFs received during the quarter Total revenue for 3Q 2025 was $XXXXX million including U.S. net product sales of $XXXXX million Retired remaining $XX million of 2025 convertible notes and achieved $XX million EU market access milestone further strengthening financial foundation 2025 KDIGO guidelines and streamlined REMS monitoring strengthen FILSPARIs position as a foundational nephroprotective therapy for IgAN Company well-positioned for potential FDA approval and commercial"
X Link 2025-10-30T20:24Z 9411 followers, 16.8K engagements

"$RKT As previously reported Oppenheimer analyst Chad Larkin initiated coverage of Rocket Companies with an Outperform rating and $XX price target. The firm believes Rocket represents the best way to invest in residential real estate as rates fall and drive refinance demand. In addition after acquiring Redfin and Mr. Cooper Rocket has created the best top of funnel to capture and monetize the life cycle of real estate Oppenheimer says. While the firm expects purchase demand to remain weak as affordability continues to be challenged refinance demand will increase if mortgage rates continue to"
X Link 2025-11-13T12:46Z 9409 followers, 3618 engagements

"$NUVB strong eod"
X Link 2025-12-03T20:55Z 9410 followers, 1363 engagements

"$SNPS $NVDA NVIDIA and Synopsys Announce Strategic Partnership to Revolutionize Engineering and Design"
X Link 2025-12-01T13:04Z 9415 followers, 2996 engagements

"$AEO AEO Total revenue increased X% to a record $XXX billion driven by total comparable sales increase of X% with positive results across brands Aerie comps +11% American Eagle comps +1% Momentum continues raises fourth quarter operating income guidance to $XXX to $XXX million on comp growth of X% to 9%"
X Link 2025-12-02T21:11Z 9412 followers, 4010 engagements

"$VSCO hitting 50s"
X Link 2025-12-08T19:40Z 9411 followers, 1205 engagements

"$TVTX intra block today"
X Link 2025-12-08T20:24Z 9415 followers, 1322 engagements

"$RLMD holding well"
X Link 2025-12-09T14:50Z 9415 followers, XXX engagements

"$SG decent come back one of sqz candidates"
X Link 2025-12-09T18:06Z 9415 followers, 1210 engagements

"$TVTX flaggy"
X Link 2025-11-24T17:54Z 9414 followers, 2473 engagements

"$TE Alliance Global analyst Jake Sekelsky initiated coverage of T1 Energy with a Buy rating and $XXXX price target. The firm believes T1 is positioned to become a leading vertically integrated solar manufacturer. The company will serve as a "key player" in securing the broader solar supply chain in the United States the analyst tells investors in a research note. Alliance says current share price levels "represent an attractive entry point ahead of a catalyst-rich 2026.""
X Link 2025-12-09T12:50Z 9415 followers, 3213 engagements

"$WRBY watching for continuation"
X Link 2025-12-09T14:41Z 9415 followers, 2037 engagements

"$APGE Deutsche Bank initiated coverage of Apogee Therapeutics with a Buy rating and $XXX price target"
X Link 2025-12-09T23:12Z 9415 followers, 2159 engagements

creator/x::zohmbastic
/creator/x::zohmbastic